Gene Therapy for Tumors of the Central Nervous System

This publication has 70 references indexed in Scilit:

• An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
  Science, 1996
• Treatment of Advanced CNS Malignancies with the Recombinant Adenovirus H5.010RSVTK: A Phase I Trial. University of Pennsylvania Medical Center, Philadelphia
  Human Gene Therapy, 1996
• p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.
  Proceedings of the National Academy of Sciences, 1995
• Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats
  Neurological Research, 1995
• Gene Expression from Recombinant Viral Vectors in the Central Nervous System after Blood-Brain Barrier Disruption
  Neurosurgery, 1995
• Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.
  Proceedings of the National Academy of Sciences, 1994
• Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus Vectors
  Human Gene Therapy, 1994
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
  Proceedings of the National Academy of Sciences, 1993
• A model system for in vivo gene transfer into the central nervous system using an adenoviral vector
  Nature Genetics, 1993
• In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors
  Science, 1992